Oxygenta Pharmaceutical Limited

₹50.86As of Sun 8 Nov 2026, 12:00 UTC
BSE:524636Healthcare
Country India
PE (Fwd) •••
TSR 5Y CAGR 27.56%
Div yield —
ROE —
Pharmaceutical Preparations
Beta (5Y) 0.73
PE TTM —
TSR TTM (20.13%)
Mkt cap ₹1.881B
ROIC (113.78%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹55
7.61%
(72.88%)
Hold 12|3|1|10|5
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.67
0.66
0.68
0.72
16.53%
9.16%
0.85%
6.31%
Revenue₹M
90.65
90.35
91.93
94.51
2.63%
0.62%
0.15%
2.64%
Peers (US$19.08M)
Cap (US$)
PE
18.95M
9.266x
18.82M
5.918x
19.32M
8.765x
Capital
TTM
5Y
10Y
Leveragex
0.667
0.024
—
EBIT/Intx
0.723
0.171
0.165
Own earn%
88.62
(44.92)
(44.66)
Sh yield%
47.12
23.40
21.99
Owners
Insiders/Inst%
8.78
55.63
Short interest%
4.55
SBC / revenue%
5.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
14–18
$1 testx
—
Incr. ROIC%
13